Thursday, November 12, 2026

IMF Chart Illustrates How European Union Is Crucial to UK's Finance Industry

The IMF's April 2017 Global Financial Stability Report illustrated the UK's deep financial linkages with the EU, highlighting potential Brexit implications for Britain's finance industry.

LM Salvado
LM Salvado

June 4, 2017

Theresa May
The International Monetary Fund’s Global Financial Stability report makes the case of how crucial the European Union is to the Uk's finance industry. The GFSR (Global Financial Stability Report) is a report by the IMF that's published twice a year and which draws out the financial ramifications of economic issues highlighted in the IMF’s World Economic Outlook (WEO). On page 45 of the GFSR April 2017, the graphic "Figure 1.3.1." shows measures of financial linkages between the United Kingdom and the European Union that might be affected by the BREXIT scenario. [caption id="attachment_1590" align="aligncenter" width="550"]BREXIT - IMF - Global Financial Stability Report April 2017 BREXIT - IMF - Global Financial Stability Report April 2017[/caption] According to the IMF, here are some of the examples of what could be at stake for the United Kingdom’s financial services industry:
  • 69% of EU-based employees of the top five U.S. investment banks located in the UK.
  • Of the over-the-counter trading in foreign exchange derivatives in the United Kingdom, Germany, and France, the UK share comes to 89%.
  • EU27 capital markets activity conducted in the UK - 66%
  • EU share of total stock of FDI in the UK - 56%
  • Share of London wholesale banking activities related to EU27-based clients - 35%
  • UK share of EU IPOs 27%
The United Kingdom plays a key role in the global financial network which stems from a "combination of factors, including concentration of capital and risk management, as well as the availability of ancillary financial services and expertise", says the IMF.
"The implications for EU-U.K. euro cross-border payments systems could be substantial. The United Kingdom may cease to be part of the Single Euro Payments Area unless membership is retained. The cost of making international payments could increase notably, affecting international activity."
IMF's Global Financial Stability Report - April 2017
In case no agreement is reached, banks have started preparing for a worst-case scenario. According to the IMF, Brexit-related costs might also increase the burden on banks due to:
  • "Duplication of some activities and business structures in different locations"
  • "Operating in different regulatory regimes"
The EU-U.K. euro cross-border payments systems could also change in the case that the United Kingdom ceases to be part of the Single Euro Payments Area. According to the IMF, "the cost of making international payments could increase notably, affecting international activity." The uncertainty levels are high regarding the outcomes of the BREXIT negotiations and any conjectures of financial stability or instability are difficult to estimate. There is even the suggestion the EU would benefit from a BREXIT scenario where "financial stability benefits could arise from a less concentrated banking system throughout Europe", says the IMF.
LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com